Global CGT Drugs Production, Demand and Key Producers, 2022-2028
This report studies the global CGT Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CGT Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGT Drugs that contribute to its increasing demand across many markets.
The global CGT Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CGT Drugs total production and demand, 2017-2028, (K Units)
Global CGT Drugs total production value, 2017-2028, (USD Million)
Global CGT Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CGT Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CGT Drugs domestic production, consumption, key domestic manufacturers and share
Global CGT Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CGT Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CGT Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CGT Drugs market based on the following parameters – headquarters, production locations, products portfolio, CGT Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGT Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CGT Drugs Market, By Region:
1. How big is the global CGT Drugs market?
2. What is the demand of the global CGT Drugs market?
3. What is the year over year growth of the global CGT Drugs market?
4. What is the production and production value of the global CGT Drugs market?
5. Who are the key producers in the global CGT Drugs market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for CGT Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGT Drugs that contribute to its increasing demand across many markets.
The global CGT Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CGT Drugs total production and demand, 2017-2028, (K Units)
Global CGT Drugs total production value, 2017-2028, (USD Million)
Global CGT Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CGT Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CGT Drugs domestic production, consumption, key domestic manufacturers and share
Global CGT Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CGT Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CGT Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CGT Drugs market based on the following parameters – headquarters, production locations, products portfolio, CGT Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGT Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CGT Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- CAR-T Therapy
- Viral Vector Therapy
- Stem Cell Therapy
- Oncolytic Virus Therapy
- Rare Disease
- Tumor Disease
- Eye Disease
- Others
- Janssen Biotech
- Celgene Corporation
- Juno Therapeutics
- Kite Pharma
- Novartis
- Spark Therapeutics
- Amgen
- Bluebird Bio
- GSK
- Orchard Therapeutics
- Sequoia
- Fosun Kite Biotechnology
- Sunway Biotech
- SiBiono
1. How big is the global CGT Drugs market?
2. What is the demand of the global CGT Drugs market?
3. What is the year over year growth of the global CGT Drugs market?
4. What is the production and production value of the global CGT Drugs market?
5. Who are the key producers in the global CGT Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CGT Drugs Introduction
1.2 World CGT Drugs Supply & Forecast
1.2.1 World CGT Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World CGT Drugs Production (2017-2028)
1.2.3 World CGT Drugs Pricing Trends (2017-2028)
1.3 World CGT Drugs Production by Region
1.3.1 World CGT Drugs Production Value by Region (2017-2028)
1.3.2 World CGT Drugs Production by Region (2017-2028)
1.3.3 World CGT Drugs Average Price by Region (2017-2028)
1.3.4 North America CGT Drugs Production (2017-2028)
1.3.5 Europe CGT Drugs Production (2017-2028)
1.3.6 China CGT Drugs Production (2017-2028)
1.3.7 Japan CGT Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CGT Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CGT Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CGT Drugs Demand (2017-2028)
2.2 World CGT Drugs Consumption by Region
2.2.1 World CGT Drugs Consumption by Region (2017-2022)
2.2.2 World CGT Drugs Consumption Forecast by Region (2023-2028)
2.3 United States CGT Drugs Consumption (2017-2028)
2.4 China CGT Drugs Consumption (2017-2028)
2.5 Europe CGT Drugs Consumption (2017-2028)
2.6 Japan CGT Drugs Consumption (2017-2028)
2.7 South Korea CGT Drugs Consumption (2017-2028)
2.8 ASEAN CGT Drugs Consumption (2017-2028)
2.9 India CGT Drugs Consumption (2017-2028)
3 WORLD CGT DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CGT Drugs Production Value by Manufacturer (2017-2022)
3.2 World CGT Drugs Production by Manufacturer (2017-2022)
3.3 World CGT Drugs Average Price by Manufacturer (2017-2022)
3.4 CGT Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CGT Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CGT Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for CGT Drugs in 2021
3.6 CGT Drugs Market: Overall Company Footprint Analysis
3.6.1 CGT Drugs Market: Region Footprint
3.6.2 CGT Drugs Market: Company Product Type Footprint
3.6.3 CGT Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CGT Drugs Production Value Comparison
4.1.1 United States VS China: CGT Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CGT Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CGT Drugs Production Comparison
4.2.1 United States VS China: CGT Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CGT Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CGT Drugs Consumption Comparison
4.3.1 United States VS China: CGT Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CGT Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CGT Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CGT Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CGT Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China CGT Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CGT Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CGT Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CGT Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CGT Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CGT Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CGT Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 CAR-T Therapy
5.2.2 Viral Vector Therapy
5.2.3 Stem Cell Therapy
5.2.4 Oncolytic Virus Therapy
5.3 Market Segment by Type
5.3.1 World CGT Drugs Production by Type (2017-2028)
5.3.2 World CGT Drugs Production Value by Type (2017-2028)
5.3.3 World CGT Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CGT Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Rare Disease
6.2.2 Tumor Disease
6.2.3 Eye Disease
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World CGT Drugs Production by Application (2017-2028)
6.3.2 World CGT Drugs Production Value by Application (2017-2028)
6.3.3 World CGT Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Janssen Biotech
7.1.1 Janssen Biotech Details
7.1.2 Janssen Biotech Major Business
7.1.3 Janssen Biotech CGT Drugs Product and Services
7.1.4 Janssen Biotech CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Janssen Biotech Recent Developments/Updates
7.1.6 Janssen Biotech Competitive Strengths & Weaknesses
7.2 Celgene Corporation
7.2.1 Celgene Corporation Details
7.2.2 Celgene Corporation Major Business
7.2.3 Celgene Corporation CGT Drugs Product and Services
7.2.4 Celgene Corporation CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Celgene Corporation Recent Developments/Updates
7.2.6 Celgene Corporation Competitive Strengths & Weaknesses
7.3 Juno Therapeutics
7.3.1 Juno Therapeutics Details
7.3.2 Juno Therapeutics Major Business
7.3.3 Juno Therapeutics CGT Drugs Product and Services
7.3.4 Juno Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Juno Therapeutics Recent Developments/Updates
7.3.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.4 Kite Pharma
7.4.1 Kite Pharma Details
7.4.2 Kite Pharma Major Business
7.4.3 Kite Pharma CGT Drugs Product and Services
7.4.4 Kite Pharma CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kite Pharma Recent Developments/Updates
7.4.6 Kite Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis CGT Drugs Product and Services
7.5.4 Novartis CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Spark Therapeutics
7.6.1 Spark Therapeutics Details
7.6.2 Spark Therapeutics Major Business
7.6.3 Spark Therapeutics CGT Drugs Product and Services
7.6.4 Spark Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Spark Therapeutics Recent Developments/Updates
7.6.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen CGT Drugs Product and Services
7.7.4 Amgen CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 Bluebird Bio
7.8.1 Bluebird Bio Details
7.8.2 Bluebird Bio Major Business
7.8.3 Bluebird Bio CGT Drugs Product and Services
7.8.4 Bluebird Bio CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bluebird Bio Recent Developments/Updates
7.8.6 Bluebird Bio Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK CGT Drugs Product and Services
7.9.4 GSK CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Orchard Therapeutics
7.10.1 Orchard Therapeutics Details
7.10.2 Orchard Therapeutics Major Business
7.10.3 Orchard Therapeutics CGT Drugs Product and Services
7.10.4 Orchard Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Orchard Therapeutics Recent Developments/Updates
7.10.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.11 Sequoia
7.11.1 Sequoia Details
7.11.2 Sequoia Major Business
7.11.3 Sequoia CGT Drugs Product and Services
7.11.4 Sequoia CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sequoia Recent Developments/Updates
7.11.6 Sequoia Competitive Strengths & Weaknesses
7.12 Fosun Kite Biotechnology
7.12.1 Fosun Kite Biotechnology Details
7.12.2 Fosun Kite Biotechnology Major Business
7.12.3 Fosun Kite Biotechnology CGT Drugs Product and Services
7.12.4 Fosun Kite Biotechnology CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Fosun Kite Biotechnology Recent Developments/Updates
7.12.6 Fosun Kite Biotechnology Competitive Strengths & Weaknesses
7.13 Sunway Biotech
7.13.1 Sunway Biotech Details
7.13.2 Sunway Biotech Major Business
7.13.3 Sunway Biotech CGT Drugs Product and Services
7.13.4 Sunway Biotech CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Sunway Biotech Recent Developments/Updates
7.13.6 Sunway Biotech Competitive Strengths & Weaknesses
7.14 SiBiono
7.14.1 SiBiono Details
7.14.2 SiBiono Major Business
7.14.3 SiBiono CGT Drugs Product and Services
7.14.4 SiBiono CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 SiBiono Recent Developments/Updates
7.14.6 SiBiono Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CGT Drugs and Key Manufacturers
8.2 CGT Drugs Manufacturing Costs
8.3 CGT Drugs Production Process
8.4 CGT Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CGT Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CGT Drugs Typical Distributors
9.3 CGT Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 CGT Drugs Introduction
1.2 World CGT Drugs Supply & Forecast
1.2.1 World CGT Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World CGT Drugs Production (2017-2028)
1.2.3 World CGT Drugs Pricing Trends (2017-2028)
1.3 World CGT Drugs Production by Region
1.3.1 World CGT Drugs Production Value by Region (2017-2028)
1.3.2 World CGT Drugs Production by Region (2017-2028)
1.3.3 World CGT Drugs Average Price by Region (2017-2028)
1.3.4 North America CGT Drugs Production (2017-2028)
1.3.5 Europe CGT Drugs Production (2017-2028)
1.3.6 China CGT Drugs Production (2017-2028)
1.3.7 Japan CGT Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CGT Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CGT Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CGT Drugs Demand (2017-2028)
2.2 World CGT Drugs Consumption by Region
2.2.1 World CGT Drugs Consumption by Region (2017-2022)
2.2.2 World CGT Drugs Consumption Forecast by Region (2023-2028)
2.3 United States CGT Drugs Consumption (2017-2028)
2.4 China CGT Drugs Consumption (2017-2028)
2.5 Europe CGT Drugs Consumption (2017-2028)
2.6 Japan CGT Drugs Consumption (2017-2028)
2.7 South Korea CGT Drugs Consumption (2017-2028)
2.8 ASEAN CGT Drugs Consumption (2017-2028)
2.9 India CGT Drugs Consumption (2017-2028)
3 WORLD CGT DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CGT Drugs Production Value by Manufacturer (2017-2022)
3.2 World CGT Drugs Production by Manufacturer (2017-2022)
3.3 World CGT Drugs Average Price by Manufacturer (2017-2022)
3.4 CGT Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CGT Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CGT Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for CGT Drugs in 2021
3.6 CGT Drugs Market: Overall Company Footprint Analysis
3.6.1 CGT Drugs Market: Region Footprint
3.6.2 CGT Drugs Market: Company Product Type Footprint
3.6.3 CGT Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CGT Drugs Production Value Comparison
4.1.1 United States VS China: CGT Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CGT Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CGT Drugs Production Comparison
4.2.1 United States VS China: CGT Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CGT Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CGT Drugs Consumption Comparison
4.3.1 United States VS China: CGT Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CGT Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CGT Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CGT Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CGT Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China CGT Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CGT Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CGT Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CGT Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CGT Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CGT Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CGT Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CGT Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 CAR-T Therapy
5.2.2 Viral Vector Therapy
5.2.3 Stem Cell Therapy
5.2.4 Oncolytic Virus Therapy
5.3 Market Segment by Type
5.3.1 World CGT Drugs Production by Type (2017-2028)
5.3.2 World CGT Drugs Production Value by Type (2017-2028)
5.3.3 World CGT Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CGT Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Rare Disease
6.2.2 Tumor Disease
6.2.3 Eye Disease
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World CGT Drugs Production by Application (2017-2028)
6.3.2 World CGT Drugs Production Value by Application (2017-2028)
6.3.3 World CGT Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Janssen Biotech
7.1.1 Janssen Biotech Details
7.1.2 Janssen Biotech Major Business
7.1.3 Janssen Biotech CGT Drugs Product and Services
7.1.4 Janssen Biotech CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Janssen Biotech Recent Developments/Updates
7.1.6 Janssen Biotech Competitive Strengths & Weaknesses
7.2 Celgene Corporation
7.2.1 Celgene Corporation Details
7.2.2 Celgene Corporation Major Business
7.2.3 Celgene Corporation CGT Drugs Product and Services
7.2.4 Celgene Corporation CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Celgene Corporation Recent Developments/Updates
7.2.6 Celgene Corporation Competitive Strengths & Weaknesses
7.3 Juno Therapeutics
7.3.1 Juno Therapeutics Details
7.3.2 Juno Therapeutics Major Business
7.3.3 Juno Therapeutics CGT Drugs Product and Services
7.3.4 Juno Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Juno Therapeutics Recent Developments/Updates
7.3.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.4 Kite Pharma
7.4.1 Kite Pharma Details
7.4.2 Kite Pharma Major Business
7.4.3 Kite Pharma CGT Drugs Product and Services
7.4.4 Kite Pharma CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kite Pharma Recent Developments/Updates
7.4.6 Kite Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis CGT Drugs Product and Services
7.5.4 Novartis CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Spark Therapeutics
7.6.1 Spark Therapeutics Details
7.6.2 Spark Therapeutics Major Business
7.6.3 Spark Therapeutics CGT Drugs Product and Services
7.6.4 Spark Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Spark Therapeutics Recent Developments/Updates
7.6.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen CGT Drugs Product and Services
7.7.4 Amgen CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 Bluebird Bio
7.8.1 Bluebird Bio Details
7.8.2 Bluebird Bio Major Business
7.8.3 Bluebird Bio CGT Drugs Product and Services
7.8.4 Bluebird Bio CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bluebird Bio Recent Developments/Updates
7.8.6 Bluebird Bio Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK CGT Drugs Product and Services
7.9.4 GSK CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Orchard Therapeutics
7.10.1 Orchard Therapeutics Details
7.10.2 Orchard Therapeutics Major Business
7.10.3 Orchard Therapeutics CGT Drugs Product and Services
7.10.4 Orchard Therapeutics CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Orchard Therapeutics Recent Developments/Updates
7.10.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.11 Sequoia
7.11.1 Sequoia Details
7.11.2 Sequoia Major Business
7.11.3 Sequoia CGT Drugs Product and Services
7.11.4 Sequoia CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sequoia Recent Developments/Updates
7.11.6 Sequoia Competitive Strengths & Weaknesses
7.12 Fosun Kite Biotechnology
7.12.1 Fosun Kite Biotechnology Details
7.12.2 Fosun Kite Biotechnology Major Business
7.12.3 Fosun Kite Biotechnology CGT Drugs Product and Services
7.12.4 Fosun Kite Biotechnology CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Fosun Kite Biotechnology Recent Developments/Updates
7.12.6 Fosun Kite Biotechnology Competitive Strengths & Weaknesses
7.13 Sunway Biotech
7.13.1 Sunway Biotech Details
7.13.2 Sunway Biotech Major Business
7.13.3 Sunway Biotech CGT Drugs Product and Services
7.13.4 Sunway Biotech CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Sunway Biotech Recent Developments/Updates
7.13.6 Sunway Biotech Competitive Strengths & Weaknesses
7.14 SiBiono
7.14.1 SiBiono Details
7.14.2 SiBiono Major Business
7.14.3 SiBiono CGT Drugs Product and Services
7.14.4 SiBiono CGT Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 SiBiono Recent Developments/Updates
7.14.6 SiBiono Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CGT Drugs and Key Manufacturers
8.2 CGT Drugs Manufacturing Costs
8.3 CGT Drugs Production Process
8.4 CGT Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CGT Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CGT Drugs Typical Distributors
9.3 CGT Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World CGT Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CGT Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World CGT Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World CGT Drugs Production Value Market Share by Region (2017-2022)
Table 5. World CGT Drugs Production Value Market Share by Region (2023-2028)
Table 6. World CGT Drugs Production by Region (2017-2022) & (K Units)
Table 7. World CGT Drugs Production by Region (2023-2028) & (K Units)
Table 8. World CGT Drugs Production Market Share by Region (2017-2022)
Table 9. World CGT Drugs Production Market Share by Region (2023-2028)
Table 10. World CGT Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CGT Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CGT Drugs Major Market Trends
Table 13. World CGT Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CGT Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World CGT Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CGT Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CGT Drugs Producers in 2021
Table 18. World CGT Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CGT Drugs Producers in 2021
Table 20. World CGT Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CGT Drugs Company Evaluation Quadrant
Table 22. World CGT Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CGT Drugs Production Site of Key Manufacturer
Table 24. CGT Drugs Market: Company Product Type Footprint
Table 25. CGT Drugs Market: Company Product Application Footprint
Table 26. CGT Drugs Competitive Factors
Table 27. CGT Drugs New Entrant and Capacity Expansion Plans
Table 28. CGT Drugs Mergers & Acquisitions Activity
Table 29. United States VS China CGT Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CGT Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CGT Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CGT Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CGT Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CGT Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CGT Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CGT Drugs Production by Type (2017-2022) & (K Units)
Table 49. World CGT Drugs Production by Type (2023-2028) & (K Units)
Table 50. World CGT Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World CGT Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World CGT Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CGT Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CGT Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CGT Drugs Production by Application (2017-2022) & (K Units)
Table 56. World CGT Drugs Production by Application (2023-2028) & (K Units)
Table 57. World CGT Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World CGT Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World CGT Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CGT Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Janssen Biotech Major Business
Table 63. Janssen Biotech CGT Drugs Product and Services
Table 64. Janssen Biotech CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Janssen Biotech Recent Developments/Updates
Table 66. Janssen Biotech Competitive Strengths & Weaknesses
Table 67. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Celgene Corporation Major Business
Table 69. Celgene Corporation CGT Drugs Product and Services
Table 70. Celgene Corporation CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Celgene Corporation Recent Developments/Updates
Table 72. Celgene Corporation Competitive Strengths & Weaknesses
Table 73. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Juno Therapeutics Major Business
Table 75. Juno Therapeutics CGT Drugs Product and Services
Table 76. Juno Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Juno Therapeutics Recent Developments/Updates
Table 78. Juno Therapeutics Competitive Strengths & Weaknesses
Table 79. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Kite Pharma Major Business
Table 81. Kite Pharma CGT Drugs Product and Services
Table 82. Kite Pharma CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kite Pharma Recent Developments/Updates
Table 84. Kite Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis CGT Drugs Product and Services
Table 88. Novartis CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Spark Therapeutics Major Business
Table 93. Spark Therapeutics CGT Drugs Product and Services
Table 94. Spark Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Spark Therapeutics Recent Developments/Updates
Table 96. Spark Therapeutics Competitive Strengths & Weaknesses
Table 97. Amgen Basic Information, Manufacturing Base and Competitors
Table 98. Amgen Major Business
Table 99. Amgen CGT Drugs Product and Services
Table 100. Amgen CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Amgen Recent Developments/Updates
Table 102. Amgen Competitive Strengths & Weaknesses
Table 103. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 104. Bluebird Bio Major Business
Table 105. Bluebird Bio CGT Drugs Product and Services
Table 106. Bluebird Bio CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bluebird Bio Recent Developments/Updates
Table 108. Bluebird Bio Competitive Strengths & Weaknesses
Table 109. GSK Basic Information, Manufacturing Base and Competitors
Table 110. GSK Major Business
Table 111. GSK CGT Drugs Product and Services
Table 112. GSK CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. GSK Recent Developments/Updates
Table 114. GSK Competitive Strengths & Weaknesses
Table 115. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Orchard Therapeutics Major Business
Table 117. Orchard Therapeutics CGT Drugs Product and Services
Table 118. Orchard Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Orchard Therapeutics Recent Developments/Updates
Table 120. Orchard Therapeutics Competitive Strengths & Weaknesses
Table 121. Sequoia Basic Information, Manufacturing Base and Competitors
Table 122. Sequoia Major Business
Table 123. Sequoia CGT Drugs Product and Services
Table 124. Sequoia CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sequoia Recent Developments/Updates
Table 126. Sequoia Competitive Strengths & Weaknesses
Table 127. Fosun Kite Biotechnology Basic Information, Manufacturing Base and Competitors
Table 128. Fosun Kite Biotechnology Major Business
Table 129. Fosun Kite Biotechnology CGT Drugs Product and Services
Table 130. Fosun Kite Biotechnology CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Fosun Kite Biotechnology Recent Developments/Updates
Table 132. Fosun Kite Biotechnology Competitive Strengths & Weaknesses
Table 133. Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 134. Sunway Biotech Major Business
Table 135. Sunway Biotech CGT Drugs Product and Services
Table 136. Sunway Biotech CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Sunway Biotech Recent Developments/Updates
Table 138. SiBiono Basic Information, Manufacturing Base and Competitors
Table 139. SiBiono Major Business
Table 140. SiBiono CGT Drugs Product and Services
Table 141. SiBiono CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. CGT Drugs Raw Material
Table 143. Key Manufacturers of CGT Drugs Raw Materials
Table 144. CGT Drugs Typical Distributors
Table 145. CGT Drugs Typical Customers
Table 1. World CGT Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CGT Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World CGT Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World CGT Drugs Production Value Market Share by Region (2017-2022)
Table 5. World CGT Drugs Production Value Market Share by Region (2023-2028)
Table 6. World CGT Drugs Production by Region (2017-2022) & (K Units)
Table 7. World CGT Drugs Production by Region (2023-2028) & (K Units)
Table 8. World CGT Drugs Production Market Share by Region (2017-2022)
Table 9. World CGT Drugs Production Market Share by Region (2023-2028)
Table 10. World CGT Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CGT Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CGT Drugs Major Market Trends
Table 13. World CGT Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CGT Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World CGT Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CGT Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CGT Drugs Producers in 2021
Table 18. World CGT Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CGT Drugs Producers in 2021
Table 20. World CGT Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CGT Drugs Company Evaluation Quadrant
Table 22. World CGT Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CGT Drugs Production Site of Key Manufacturer
Table 24. CGT Drugs Market: Company Product Type Footprint
Table 25. CGT Drugs Market: Company Product Application Footprint
Table 26. CGT Drugs Competitive Factors
Table 27. CGT Drugs New Entrant and Capacity Expansion Plans
Table 28. CGT Drugs Mergers & Acquisitions Activity
Table 29. United States VS China CGT Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CGT Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CGT Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CGT Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CGT Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CGT Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CGT Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CGT Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CGT Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CGT Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CGT Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CGT Drugs Production by Type (2017-2022) & (K Units)
Table 49. World CGT Drugs Production by Type (2023-2028) & (K Units)
Table 50. World CGT Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World CGT Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World CGT Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CGT Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CGT Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CGT Drugs Production by Application (2017-2022) & (K Units)
Table 56. World CGT Drugs Production by Application (2023-2028) & (K Units)
Table 57. World CGT Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World CGT Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World CGT Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CGT Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 62. Janssen Biotech Major Business
Table 63. Janssen Biotech CGT Drugs Product and Services
Table 64. Janssen Biotech CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Janssen Biotech Recent Developments/Updates
Table 66. Janssen Biotech Competitive Strengths & Weaknesses
Table 67. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Celgene Corporation Major Business
Table 69. Celgene Corporation CGT Drugs Product and Services
Table 70. Celgene Corporation CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Celgene Corporation Recent Developments/Updates
Table 72. Celgene Corporation Competitive Strengths & Weaknesses
Table 73. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Juno Therapeutics Major Business
Table 75. Juno Therapeutics CGT Drugs Product and Services
Table 76. Juno Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Juno Therapeutics Recent Developments/Updates
Table 78. Juno Therapeutics Competitive Strengths & Weaknesses
Table 79. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Kite Pharma Major Business
Table 81. Kite Pharma CGT Drugs Product and Services
Table 82. Kite Pharma CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kite Pharma Recent Developments/Updates
Table 84. Kite Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis CGT Drugs Product and Services
Table 88. Novartis CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Spark Therapeutics Major Business
Table 93. Spark Therapeutics CGT Drugs Product and Services
Table 94. Spark Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Spark Therapeutics Recent Developments/Updates
Table 96. Spark Therapeutics Competitive Strengths & Weaknesses
Table 97. Amgen Basic Information, Manufacturing Base and Competitors
Table 98. Amgen Major Business
Table 99. Amgen CGT Drugs Product and Services
Table 100. Amgen CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Amgen Recent Developments/Updates
Table 102. Amgen Competitive Strengths & Weaknesses
Table 103. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 104. Bluebird Bio Major Business
Table 105. Bluebird Bio CGT Drugs Product and Services
Table 106. Bluebird Bio CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bluebird Bio Recent Developments/Updates
Table 108. Bluebird Bio Competitive Strengths & Weaknesses
Table 109. GSK Basic Information, Manufacturing Base and Competitors
Table 110. GSK Major Business
Table 111. GSK CGT Drugs Product and Services
Table 112. GSK CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. GSK Recent Developments/Updates
Table 114. GSK Competitive Strengths & Weaknesses
Table 115. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Orchard Therapeutics Major Business
Table 117. Orchard Therapeutics CGT Drugs Product and Services
Table 118. Orchard Therapeutics CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Orchard Therapeutics Recent Developments/Updates
Table 120. Orchard Therapeutics Competitive Strengths & Weaknesses
Table 121. Sequoia Basic Information, Manufacturing Base and Competitors
Table 122. Sequoia Major Business
Table 123. Sequoia CGT Drugs Product and Services
Table 124. Sequoia CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sequoia Recent Developments/Updates
Table 126. Sequoia Competitive Strengths & Weaknesses
Table 127. Fosun Kite Biotechnology Basic Information, Manufacturing Base and Competitors
Table 128. Fosun Kite Biotechnology Major Business
Table 129. Fosun Kite Biotechnology CGT Drugs Product and Services
Table 130. Fosun Kite Biotechnology CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Fosun Kite Biotechnology Recent Developments/Updates
Table 132. Fosun Kite Biotechnology Competitive Strengths & Weaknesses
Table 133. Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table 134. Sunway Biotech Major Business
Table 135. Sunway Biotech CGT Drugs Product and Services
Table 136. Sunway Biotech CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Sunway Biotech Recent Developments/Updates
Table 138. SiBiono Basic Information, Manufacturing Base and Competitors
Table 139. SiBiono Major Business
Table 140. SiBiono CGT Drugs Product and Services
Table 141. SiBiono CGT Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. CGT Drugs Raw Material
Table 143. Key Manufacturers of CGT Drugs Raw Materials
Table 144. CGT Drugs Typical Distributors
Table 145. CGT Drugs Typical Customers
LIST OF FIGURES
Figure 1. CGT Drugs Picture
Figure 2. World CGT Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CGT Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CGT Drugs Production (2017-2028) & (K Units)
Figure 5. World CGT Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World CGT Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World CGT Drugs Production Market Share by Region (2017-2028)
Figure 8. North America CGT Drugs Production (2017-2028) & (K Units)
Figure 9. Europe CGT Drugs Production (2017-2028) & (K Units)
Figure 10. China CGT Drugs Production (2017-2028) & (K Units)
Figure 11. Japan CGT Drugs Production (2017-2028) & (K Units)
Figure 12. CGT Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CGT Drugs Demand (2017-2028) & (K Units)
Figure 15. World CGT Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States CGT Drugs Consumption (2017-2028) & (K Units)
Figure 17. China CGT Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe CGT Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan CGT Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea CGT Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CGT Drugs Consumption (2017-2028) & (K Units)
Figure 22. India CGT Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CGT Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CGT Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CGT Drugs Markets in 2021
Figure 26. United States VS China: CGT Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CGT Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CGT Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CGT Drugs in United States
Figure 30. Key Producers and Market Share of CGT Drugs in China
Figure 31. Key Producers and Market Share of CGT Drugs in Rest of World
Figure 32. World CGT Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CGT Drugs Production Value Market Share by Type in 2021
Figure 34. CAR-T Therapy
Figure 35. Viral Vector Therapy
Figure 36. Stem Cell Therapy
Figure 37. Oncolytic Virus Therapy
Figure 38. World CGT Drugs Production Market Share by Type (2017-2028)
Figure 39. World CGT Drugs Production Value Market Share by Type (2017-2028)
Figure 40. World CGT Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World CGT Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World CGT Drugs Production Value Market Share by Application in 2021
Figure 43. Rare Disease
Figure 44. Tumor Disease
Figure 45. Eye Disease
Figure 46. Others
Figure 47. World CGT Drugs Production Market Share by Application (2017-2028)
Figure 48. World CGT Drugs Production Value Market Share by Application (2017-2028)
Figure 49. World CGT Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CGT Drugs in 2021
Figure 51. Manufacturing Process Analysis of CGT Drugs
Figure 52. CGT Drugs Industrial Chain
Figure 53. Distribution Channel Breakdown for CGT Drugs Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. CGT Drugs Picture
Figure 2. World CGT Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CGT Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CGT Drugs Production (2017-2028) & (K Units)
Figure 5. World CGT Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World CGT Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World CGT Drugs Production Market Share by Region (2017-2028)
Figure 8. North America CGT Drugs Production (2017-2028) & (K Units)
Figure 9. Europe CGT Drugs Production (2017-2028) & (K Units)
Figure 10. China CGT Drugs Production (2017-2028) & (K Units)
Figure 11. Japan CGT Drugs Production (2017-2028) & (K Units)
Figure 12. CGT Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CGT Drugs Demand (2017-2028) & (K Units)
Figure 15. World CGT Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States CGT Drugs Consumption (2017-2028) & (K Units)
Figure 17. China CGT Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe CGT Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan CGT Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea CGT Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CGT Drugs Consumption (2017-2028) & (K Units)
Figure 22. India CGT Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CGT Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CGT Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CGT Drugs Markets in 2021
Figure 26. United States VS China: CGT Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CGT Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CGT Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CGT Drugs in United States
Figure 30. Key Producers and Market Share of CGT Drugs in China
Figure 31. Key Producers and Market Share of CGT Drugs in Rest of World
Figure 32. World CGT Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CGT Drugs Production Value Market Share by Type in 2021
Figure 34. CAR-T Therapy
Figure 35. Viral Vector Therapy
Figure 36. Stem Cell Therapy
Figure 37. Oncolytic Virus Therapy
Figure 38. World CGT Drugs Production Market Share by Type (2017-2028)
Figure 39. World CGT Drugs Production Value Market Share by Type (2017-2028)
Figure 40. World CGT Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World CGT Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World CGT Drugs Production Value Market Share by Application in 2021
Figure 43. Rare Disease
Figure 44. Tumor Disease
Figure 45. Eye Disease
Figure 46. Others
Figure 47. World CGT Drugs Production Market Share by Application (2017-2028)
Figure 48. World CGT Drugs Production Value Market Share by Application (2017-2028)
Figure 49. World CGT Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CGT Drugs in 2021
Figure 51. Manufacturing Process Analysis of CGT Drugs
Figure 52. CGT Drugs Industrial Chain
Figure 53. Distribution Channel Breakdown for CGT Drugs Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
